Rethinking Liver Fibrosis Staging in Patients with Hepatocellular Carcinoma: New Insights from a Large Two-Center Cohort Study

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Gunasekaran G, Bekki Y, Lourdusamy V, et al. Surgical treatments of hepatobiliary cancers. Hepatology. 2021;73(Suppl 1):128–136. doi:10.1002/hep.31325
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. doi:10.1016/j.jhep.2018.03.019
   PubMed Web of Science ®Google Scholar
• Soon G, Wee A. Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: histological perspective. Clin Mol Hepatol. 2021;27(1):44–57. doi:10.3350/cmh.2020.0181
   PubMed Web of Science ®Google Scholar
• Russo FP, Imondi A, Lynch EN, et al. When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A review. Dig Liver Dis. 2018;50(7):640–646. doi:10.1016/j.dld.2018.03.014
   PubMedGoogle Scholar
• Gheorghe G, Bungău S, Ceobanu G, et al. The non-invasive assessment of hepatic fibrosis. J Formos Med Assoc. 2021;120(2):794–803. doi:10.1016/j.jfma.2020.08.019
   PubMed Web of Science ®Google Scholar
• Smith AD, Porter KK, Elkassem AA, et al. Current imaging techniques for noninvasive staging of hepatic fibrosis. AJR Am J Roentgenol. 2019;213(1):77–89. doi:10.2214/AJR.19.21144
   PubMed Web of Science ®Google Scholar
• Karam AR, Beland MD. Liver ultrasound elastography: review of techniques and clinical applications. R I Med J. 2020;103(5):26–29.
   Google Scholar
• Akkaya HE, Erden A, Kuru ÖD, et al. Magnetic resonance elastography: basic principles, technique, and clinical applications in the liver. Diagn Interv Radiol. 2018;24(6):328–335. doi:10.5152/dir.2018.18186
   PubMed Web of Science ®Google Scholar
• Guglielmo FF, Venkatesh SK, Mitchell DG. Liver MR elastography technique and image interpretation: pearls and pitfalls. Radiographics. 2019;39(7):1983–2002. doi:10.1148/rg.2019190034
   PubMed Web of Science ®Google Scholar
• Lu Q, Ling W, Lu C, et al. Hepatocellular carcinoma: stiffness value and ratio to discriminate malignant from benign focal liver lesions. Radiology. 2015;275(3):880–888. doi:10.1148/radiol.14131164
   PubMed Web of Science ®Google Scholar
• Huang Z, Zheng W, Zhang YJ, et al. Assessing hepatic fibrosis using 2-D shear wave elastography in patients with liver tumors: a prospective single-center study. Ultrasound Med Biol. 2017;43(11):2522–2529. doi:10.1016/j.ultrasmedbio.2017.07.003
   PubMed Web of Science ®Google Scholar
• Zheng W, Zhou ZG, Wong CH, et al. Evaluation of liver parenchyma stiffness in patients with liver tumours: optimal strategy for shear wave elastography. Eur Radiol. 2019;29(3):1479–1488. doi:10.1007/s00330-018-5676-8
   PubMed Web of Science ®Google Scholar
• Xie LT, Gu JH, Chai WL, et al. Pre-operative detection of liver fibrosis in hepatocellular carcinoma patients using 2D shear wave elastography: where to measure? Ultrasound Med Biol. 2020;46(6):1412–1423. doi:10.1016/j.ultrasmedbio.2020.02.012
   PubMed Web of Science ®Google Scholar
• Collins GS, Reitsma JB, Altman DG, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015;162:55–63. doi:10.7326/M14-0697
   PubMed Web of Science ®Google Scholar
• Marrero JA, Kulik LM, Sirlin C, et al. Diagnosis, staging and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the study of liver diseases. Hepatology. 2018;68:723–750. doi:10.1002/hep.29913
   PubMed Web of Science ®Google Scholar
• Ikai I, Arii S, Okazaki M, et al. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res. 2007;37:676–691. doi:10.1111/j.1872-034X.2007.00119.x
   PubMed Web of Science ®Google Scholar
• Esaki M, Shimada K, Sano T, et al. Surgical results for hepatocellular carcinoma with bile duct invasion: a clinicopathologic comparison between macroscopic and microscopic tumor thrombus. J Surg Oncol. 2005;90:226–232. doi:10.1002/jso.20260
   PubMed Web of Science ®Google Scholar
• Lok AS, Ghany MG, Goodman ZD, et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology. 2005;42(2):282–292. doi:10.1002/hep.20772
   PubMed Web of Science ®Google Scholar
• Cross TJ, Rizzi P, Berry PA, et al. King’s Score: an accurate marker of cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol. 2009;21(7):730–738. doi:10.1097/MEG.0b013e32830dfcb3
   PubMed Web of Science ®Google Scholar
• Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518–526. doi:10.1053/jhep.2003.50346
   PubMed Web of Science ®Google Scholar
• Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 2007;46(1):32–36. doi:10.1002/hep.21669
   PubMed Web of Science ®Google Scholar
• Lemoine M, Shimakawa Y, Nayagam S, et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut. 2016;65:1369–1376. doi:10.1136/gutjnl-2015-309260
   PubMed Web of Science ®Google Scholar
• Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-The ALBI grade. J Clin Oncol. 2015;33(6):550–558. doi:10.1200/JCO.2014.57.9151
   PubMed Web of Science ®Google Scholar
• Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut. 2003;52(1):134–139. doi:10.1136/gut.52.1.134
   PubMed Web of Science ®Google Scholar
• Huo TI, Wang YW, Yang YY, et al. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis. Liver Int. 2007;27(4):498–506. doi:10.1111/j.1478-3231.2007.01445.x
   PubMed Web of Science ®Google Scholar
• Faitot F, Allard MA, Pittau G, et al. Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantation. Hepatology. 2015;62(1):179–187. doi:10.1002/hep.27864
   PubMed Web of Science ®Google Scholar
• Xu W, Li R, Liu F. Novel Prognostic nomograms for predicting early and late recurrence of hepatocellular carcinoma after curative hepatectomy. Cancer Manag Res. 2020;12:1693–1712. doi:10.2147/CMAR.S241959
   PubMed Web of Science ®Google Scholar
• Xu W, Liu F, Shen X, Li R. Prognostic nomograms for patients with hepatocellular carcinoma after curative hepatectomy, with a focus on recurrence timing and post-recurrence management. J Hepatocell Carcinoma. 2020;7:233–256. doi:10.2147/JHC.S271498
   PubMed Web of Science ®Google Scholar
• Mamone G, Cortis K, Sarah A, Caruso S, Miraglia R. Hepatic morphology abnormalities: beyond cirrhosis. Abdom Radiol. 2018;43(7):1612–1626. doi:10.1007/s00261-017-1351-9
   PubMed Web of Science ®Google Scholar
• Kamarajah SK, Frankel TL, Sonnenday C, et al. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): a surveillance, epidemiology, end results (SEER) analysis. J Surg Oncol. 2018;117(4):644–650. doi:10.1002/jso.24908
   PubMed Web of Science ®Google Scholar
• Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954;7(3):462–503. doi:10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E
   PubMed Web of Science ®Google Scholar
• Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991;13(3):372–374. doi:10.1016/0168-8278(91)90084-O
   PubMed Web of Science ®Google Scholar
• Braga M, Capretti G, Pecorelli N, et al. A prognostic score to predict major complications after pancreaticoduodenectomy. Ann Surg. 2011;254:702–707; discussion 707–708. doi:10.1097/SLA.0b013e31823598fb
   PubMed Web of Science ®Google Scholar
• Herrmann E, de Lédinghen V, Cassinotto C, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis. Hepatology. 2018;67:260–272. doi:10.1002/hep.29179
   PubMed Web of Science ®Google Scholar
• O’Shea A, Pierce TT. US Elastography in hepatic fibrosis-radiology in training. Radiology. 2021;299:203893.
   Web of Science ®Google Scholar
• Chou CT, Chen RC, Wu WP, et al. Prospective comparison of the diagnostic performance of magnetic resonance elastography with acoustic radiation force impulse elastography for pre-operative staging of hepatic fibrosis in patients with hepatocellular carcinoma. Ultrasound Med Biol. 2017;43(12):2783–2790. doi:10.1016/j.ultrasmedbio.2017.08.1879
   PubMed Web of Science ®Google Scholar
• Lubner MG, Jones D, Said A, et al. Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virus. Abdom Radiol. 2018;43(11):2980–2986. doi:10.1007/s00261-018-1572-6
   PubMed Web of Science ®Google Scholar
• De Vos N, Sartoris R, Cauchy F, et al. Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT. Abdom Radiol. 2020;45(2):365–372. doi:10.1007/s00261-019-02355-y
   PubMed Web of Science ®Google Scholar
• Hobeika C, Cauchy F, Sartoris R, et al. Relevance of liver surface nodularity for preoperative risk assessment in patients with resectable hepatocellular carcinoma. Br J Surg. 2020;107(7):878–888. doi:10.1002/bjs.11511
   PubMed Web of Science ®Google Scholar
• Pickhardt PJ, Graffy PM, Said A, et al. Multiparametric CT for noninvasive staging of hepatitis C virus-related liver fibrosis: correlation with the histopathologic fibrosis score. AJR Am J Roentgenol. 2019;212(3):547–553. doi:10.2214/AJR.18.20284
   PubMed Web of Science ®Google Scholar
• Li S, Sun X, Chen M, et al. Liver fibrosis conventional and molecular imaging diagnosis update. J Liver. 2019;8(1):236. doi:10.35248/2167-0889.19.8.236
   PubMedGoogle Scholar
• Jang W, Jo S, Song JS, et al. Comparison of diffusion-weighted imaging and MR elastography in staging liver fibrosis: a meta-analysis. Abdom Radiol. 2021;46:3889–3907. doi:10.1007/s00261-021-03055-2
   PubMed Web of Science ®Google Scholar
• Zhou SJ, Zhang EL, Liang BY, et al. Morphologic severity of cirrhosis determines the extent of liver resection in patients with hepatocellular carcinoma and Child-Pugh grade A cirrhosis. J Surg Res. 2016;200(2):444–451. doi:10.1016/j.jss.2015.08.027
   PubMed Web of Science ®Google Scholar
• Kim SU, Jung KS, Lee S, et al. Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma. Liver Int. 2014;34(7):1008–1017. doi:10.1111/liv.12475
   PubMed Web of Science ®Google Scholar
• Procopet B, Berzigotti A. Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep. 2017;5(2):79–89.
   Google Scholar
• Chen PC, Chen BH, Huang CH, et al. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol. 2019;31(10):1256–1263. doi:10.1097/MEG.0000000000001481
   PubMed Web of Science ®Google Scholar
• Wan SZ, Nie Y, Zhang Y, et al. Assessing the prognostic performance of the Child-Pugh, model for end-stage liver disease, and albumin-bilirubin scores in patients with decompensated cirrhosis: a large Asian cohort from gastroenterology department. Dis Markers. 2020;2020:5193028. doi:10.1155/2020/5193028
   PubMed Web of Science ®Google Scholar
• Xun YH, Shi JP, Li CQ, et al. Prognostic performance of a series of model for end-stage liver disease and respective Δ scores in patients with hepatitis B acute-on-chronic liver failure. Mol Med Rep. 2014;9(5):1559–1568. doi:10.3892/mmr.2014.1983
   PubMed Web of Science ®Google Scholar
• Panasiuk A, Prokopowicz D, Zak J, et al. Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4. Hepatogastroenterology. 2001;48(39):818–822.
   PubMedGoogle Scholar
• Coskun BD, Dizdar OS, Baspınar O, et al. Usefulness of the neutrophil-to-lymphocyte ratio and platelet morphologic parameters in predicting hepatic fibrosis in chronic hepatitis C patients. Ann Clin Lab Sci. 2016;46(4):380–386.
   PubMed Web of Science ®Google Scholar
• Wang J, Xia J, Yan X, et al. Plateletcrit as a potential index for predicting liver fibrosis in chronic hepatitis B. J Viral Hepat. 2020;27(6):602–609. doi:10.1111/jvh.13264
   PubMed Web of Science ®Google Scholar
• Michalak A, Cichoż-Lach H, Guz M, et al. Plateletcrit and mean platelet volume in the evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients. Biomed Res Int. 2021;2021:8867985. doi:10.1155/2021/8867985
   PubMed Web of Science ®Google Scholar
• Zhuang Y, Ding H, Zhang Y, et al. Two-dimensional shear-wave elastography performance in the noninvasive evaluation of liver fibrosis in patients with chronic hepatitis B: comparison with serum fibrosis indexes. Radiology. 2017;283(3):873–882. doi:10.1148/radiol.2016160131
   PubMed Web of Science ®Google Scholar
• Leitão HS, Doblas S, Garteiser P, et al. Hepatic fibrosis, inflammation, and steatosis: influence on the MR viscoelastic and diffusion parameters in patients with chronic liver disease. Radiology. 2017;283:98–107. doi:10.1148/radiol.2016151570
   PubMed Web of Science ®Google Scholar
• Marti-Aguado D, Rodríguez-Ortega A, Alberich-Bayarri A, et al. Magnetic resonance imaging analysis of liver fibrosis and inflammation: overwhelming gray zones restrict clinical use. Abdom Radiol. 2020;45(11):3557–3568. doi:10.1007/s00261-020-02713-1
   PubMed Web of Science ®Google Scholar